AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9561593
Drug: artesunate 600
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: artesunate 600 mg over 2 days and mefloquine 1,250 mg in divided doses
Trial: 9561593
Drug: artemether 640
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: artemether 640 mg over 2 days and mefloquine 1,250 mg in divided doses
Trial: 9561593
Drug: artesunate alone
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: artesunate alone 700 mg over 5 days
Trial: 9561593
Drug: artemether alone
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: artemether alone 800 mg over 5 days
Trial: 9561593
Drug: mefloquine 1,250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mefloquine 1,250 mg in divided doses
Trial: 9561593
Drug: artesunate 600
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: artesunate 600 mg over 2 days and mefloquine 750 mg
Trial: 1529904
Drug: Flecainide (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide (300 mg/day)
Trial: 3872627
Drug: Ceftriaxone 500
RxNorm normalized name: ceftriaxone 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 500 mg in a single intramuscular dose
Trial: 3872627
Drug: Trimethoprim 160
RxNorm normalized name: trimethoprim 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim 160 mg-800 mg of sulfamethoxazole orally twice daily for 7 days
Trial: 27788310
Drug: Dose-increment group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-increment group (olanzapine doubled to 20 mg/d or risperidone doubled to 6 mg/d)
Trial: 27788310
Drug: Continuation group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation group (olanzapine 10 mg/d or risperidone 3 mg/d)
Trial: 27788310
Drug: Dose-increment group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-increment group
Trial: 23365557
Drug: Exenatide 10
RxNorm normalized name: EXENATIDE 10MCG/DOSE 2.4ML 60D PEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide 10 μg twice daily (EX10BID)
Trial: 23365557
Drug: Liraglutide 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide 1.2 mg once daily (LIR1.2)
Trial: 18955428
Drug: Aquatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aquatic therapy (Ai Chi and Halliwick methods)
Trial: 18955428
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (gym exercises)
Trial: 11426917
Drug: Montelukast, Zafirlukast,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast, Zafirlukast, Zileuton (antileukotriene agents)
Trial: 11426917
Drug: Antileukotriene agents
RxNorm normalized name: ANTIASTHMA,ANTILEUKOTRIENES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antileukotriene agents in combination with low-dose or high-dose corticosteroids
Trial: 11426917
Drug: Antileukotriene agents
RxNorm normalized name: ANTIASTHMA,ANTILEUKOTRIENES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antileukotriene agents
Trial: 171780
Drug: Tinidazole 800
RxNorm normalized name: Tinidazole
DrugBank: Tinidazole (DB00911)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tinidazole 800 mg t.d.s. for 5 days
Trial: 31825067
Drug: Continuous energy
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous energy restriction (CER) - 25% daily energy restriction
Trial: 26384978
Drug: Cognitive-Behavioral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Therapy (CBT) - Coping Cat
Trial: 15103438
Drug: fosfluconazole (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fosfluconazole (1000 mg bolus intravenous injection)
Trial: 15103438
Drug: fluconazole (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fluconazole (800 mg intravenous infusion)
Trial: 12234028
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg preoperatively for 10-14 days
Trial: 8088258
Drug: Gabapentin (Neurontin)
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin (Neurontin) as add-on therapy at dosages of 600-2400 mg/day
Trial: 8088258
Drug: Gabapentin (Neurontin)
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin (Neurontin) as add-on therapy
Trial: 3668801
Drug: oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oral solution
Trial: 2776093
Drug: film‐coated tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: film‐coated tablets
Trial: 2776093
Drug: enteric‐coated tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enteric‐coated tablets
Trial: 30383097
Drug: Young fresh
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Young fresh frozen plasma (yFFP) from male donors, 1 unit (approximately 250 mL) infused once weekly for 4 weeks
Trial: 30383097
Drug: Saline (placebo),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (placebo), 250 mL infused once weekly for 4 weeks
Trial: 28294641
Drug: liraglutide added
RxNorm normalized name: Liraglutide
DrugBank: Liraglutide (DB06655)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: liraglutide added to basal insulin
Trial: 25841891
Drug: Intramuscular procaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular procaine benzylpenicillin and gentamicin once per day for 7 days (group A)
Trial: 25841891
Drug: Intramuscular gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular gentamicin once per day and oral amoxicillin twice per day for 7 days (group B)
Trial: 25841891
Drug: Intramuscular procaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular procaine benzylpenicillin and gentamicin once per day for 2 days, then oral amoxicillin twice per day for 5 days (group C)
Trial: 25841891
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (standard treatment)
Trial: 21671851
Drug: Disease-modifying drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease-modifying drugs (DMDs) for RRMS
Trial: 17364435
Drug: Telephone administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telephone administration of ALSFRS-R
Trial: 15051844
Drug: Multiple micronutrient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple micronutrient supplements (MM), n = 142
Trial: 15051844
Drug: Iron-only supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-only supplements (FE), n = 148
Trial: 11173790
Drug: GV 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GV 800 mg/400 mg
Trial: 11173790
Drug: GV 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GV 800 mg/200 mg
Trial: 9060194
Drug: Ethanol (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.75 ml/kg)
Trial: 2202619
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (4 x 1 tablet a day, 800 mg total daily dose)
Trial: 2202619
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (2 x 2 tablets a day, 800 mg total daily dose)
Trial: 2202619
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (2 x 1 tablet a day, 400 mg total daily dose)
Trial: 7196807
Drug: Cisplatin 90
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 90 mg/m2
Trial: 7196807
Drug: Cisplatin 30
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 30 mg/m2 and 90 mg/m2
Trial: 28910233
Drug: Beef protein
RxNorm normalized name: Beef
DrugBank: Beef (DB10509)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beef protein (20 g mixed with plain water once a day)
Trial: 28910233
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (20 g mixed with plain water once a day)
Trial: 28910233
Drug: Carbohydrate (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate (20 g mixed with plain water once a day)
Trial: 18575293
Drug: Propofol-MCT/LCT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol-MCT/LCT plus 20 mg lidocaine
Trial: 10715674
Drug: Primaquine 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine 45 mg (given on day 8)
Trial: 4052276
Drug: Intravenous and
RxNorm normalized name: immune globulin intravenous and subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous and oral propranolol (n = 44)
Trial: 4052276
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (n = 35)
Trial: 30552595
Drug: Reflexology intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reflexology intervention (four weekly sessions, 30 min each)
Trial: 29695211
Drug: Oral Nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Nutritional Supplementation (ONS) plus Dietary Counselling (DC)
Trial: 23686730
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg) plus oral ketamine (5 mg/kg)
Trial: 23686730
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg) plus oral placebo
Trial: 17055081
Drug: Rate control
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rate control with pharmacological heart rate frequency optimization treatment combined with Holter monitoring
Trial: 17055081
Drug: Rhythm control
RxNorm normalized name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 180 mg in 1 g TOPICAL STICK [ZUSKA RHYTHM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhythm control with sinus rhythm restoration and sequential antiarrhythmic drug treatment
Trial: 12173678
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tailored mail and telephone counseling
Trial: 7789590
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg vaginal PGE2 gel
Trial: 7789590
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg intracervical PGE2
Trial: 31530607
Drug: Central line
RxNorm normalized name: CENTRAL LINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Central line removal at 100 mL/kg/day of enteral intake
Trial: 31530607
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: Central line removal at 140 mL/kg/day of enteral intake
Trial: 25660340
Drug: Progressive Muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progressive Muscle Relaxation therapy (PMR)
Trial: 14764189
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (twice a week for 8 weeks, total of 16 sessions)
Trial: 9597863
Drug: Cefazolin (CEZ)
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin (CEZ) administered on the day of operation
Trial: 9597863
Drug: Cefazolin (CEZ)
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin (CEZ) administered for 3 days
Trial: 9597863
Drug: Cefazolin (CEZ)
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin (CEZ) or cefotiam (CTM) administered for 2 days
Trial: 9597863
Drug: Cefazolin (CEZ)
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin (CEZ) or cefotiam (CTM) administered for 4 days
Trial: 9597863
Drug: Shorter antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shorter antimicrobial administration periods
Trial: 7940731
Drug: T cell
RxNorm normalized name: CD4CAR T cells
DrugBank: Anti-CD4 CAR T-cell therapy (DB17281)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T cell depletion using anti-CD8 and anti-CD6 antibodies plus complement (n = 28)
Trial: 27793147
Drug: Combined microsavings
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined microsavings and HIV/STI risk reduction intervention (treatment condition)
Trial: 20567051
Drug: Pressurized topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pressurized topical oxygen therapy (TWO(2)), 60-minute treatment, five times per week, pressure cycles between 5 and 50 mb
Trial: 20567051
Drug: Silver-containing dressing,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver-containing dressing, changed at least twice per week (control)
Trial: 10485768
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume breathing for 3 min at 5 l/min
Trial: 10485768
Drug: Four deep
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four deep breaths for 30 s at 5 l/min
Trial: 10485768
Drug: Four deep
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four deep breaths for 30 s at 10 l/min
Trial: 10485768
Drug: Four deep
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four deep breaths for 30 s at 20 l/min
Trial: 10485768
Drug: Eight deep
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eight deep breaths for 60 s at 10 l/min
Trial: 7575750
Drug: Alpha-lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-lipoic acid (ALA) 1000 mg/Thioctacid/500 ml NaCl
Trial: 7575750
Drug: Vehicle control
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle control (500 ml NaCl)
Trial: 28545
Drug: ID-540 (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ID-540 (0.5 mg)
Trial: 31561819
Drug: 3-monthly replacement
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 3-monthly replacement group
Trial: 31561819
Drug: 6-monthly replacement
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 6-monthly replacement group
Trial: 27470115
Drug: Dexmedetomidine 1
RxNorm normalized name: DEXMEDETOMIDINE 120MCG SUBLINGUAL FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1 µg/kg IV over 10 min before anesthesia induction, followed by 0.7 µg/kg/h infusion during operation
Trial: 27470115
Drug: Remifentanil 1
RxNorm normalized name: remifentanil 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 1 µg/kg IV bolus with induction of anesthesia, continued 0.25-0.50 µg/kg/min during operation
Trial: 23520223
Drug: Postcard intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postcard intervention (eight in 12 months) plus treatment as usual
Trial: 21628666
Drug: AS03(A)-adjuvanted H1N1v
RxNorm normalized name: AS03 Adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03(A)-adjuvanted H1N1v vaccine (3.75 μg HA)
Trial: 21628666
Drug: Nonadjuvanted H1N1v
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonadjuvanted H1N1v vaccine (15 μg HA)
Trial: 19398387
Drug: Epidural injections
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injections with varying volumes
Trial: 19398387
Drug: Epidural injections
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injections with the same volume
Trial: 19398387
Drug: Epidural injections
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injections with different volumes
Trial: 17303369
Drug: No-treatment control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment control group (C)
Trial: 7908865
Drug: Conventional intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional intravenous nutrition (0.2 g of N and 103 non-protein kJ/kg body weight)
Trial: 7908865
Drug: Intravenous nutrition
RxNorm normalized name: Intravenous nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nutrition enriched with branched-chain amino acids (0.2 g of N with 30% from branched-chain amino acids and 103 non-protein kJ/kg body weight)
Trial: 29655984
Drug: Motor affordance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Motor affordance program at home for infants (G-2)
Trial: 29655984
Drug: Motor affordance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Motor affordance program at home for infants (G-1)
Trial: 21986137
Drug: Single-injection local
RxNorm normalized name: LOCAL ANESTHETICS,INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-injection local infiltration analgesia (SLIA)
Trial: 15379315
Drug: six flavor
RxNorm normalized name: blackberry flavor
DrugBank: Blackberry (DB10628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: six flavor glutinous rehmannis pill
Trial: 9020492
Drug: Initial serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial serum concentrations of HCG > 1000 IU l(‐1)
Trial: 9020492
Drug: Initial serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial serum concentrations of AFP > 1000 IU l(‐1)
Trial: 7885970
Drug: Treatment A
RxNorm normalized name: Nix Ultra Lice Treatment And Prevention Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment A (100 mg ZDV after an 8-hour fast)
Trial: 7885970
Drug: Treatment B
RxNorm normalized name: PanOxyl Acne Treatment Bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment B (100 mg ZDV with a high-fat breakfast)
Trial: 7885970
Drug: Treatment C
RxNorm normalized name: Acne Treatment Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment C (100 mg ZDV 3 hours after a high-fat breakfast)
Trial: 2897986
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg of terfenadine and 300 mg of flurbiprofen per day
Trial: 31619442
Drug: Berberine 900
RxNorm normalized name: berberine
DrugBank: Berberine (DB04115)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Berberine 900 mg/day
Trial: 30212239
Drug: Tiotropium (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium (5 μg/day)
Trial: 30212239
Drug: No add-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No add-on therapy
Trial: 26071277
Drug: Clopidogrel loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel loading dose (300 mg or 900 mg)
Trial: 23668548
Drug: Nebulized cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized cyclosporine (300 mg of CIS, 62.5 mg/mL CsA in propylene glycol)
Trial: 23668548
Drug: Nebulized cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized cyclosporine (300 mg of CIS)
Trial: 17572575
Drug: Dexamethasone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (10 mg intravenously intraoperatively followed by a 6-day oral tapering dose of methyl-prednisone)
Trial: 17572575
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (received neither agent)
Trial: 7740468
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin plus 100 mg aspirin
Trial: 26566149
Drug: Trimethoprim, 200
RxNorm normalized name: Trimethoprim, 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim, 200 mg twice daily
Trial: 6605713
Drug: Cephalexin, 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalexin, 250 mg four times daily
Trial: 20506328
Drug: Drug Eluting
RxNorm normalized name: Drug eluting stent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Eluting Stents (DES)
Trial: 26559572
Drug: Optimal medical
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal medical therapy plus PCI (PCI group)